(Total Views: 516)
Posted On: 10/11/2021 4:55:20 PM
Post# of 148903
Could you please elucidate what you mean by "flawed and missing data provided to the FDA."
It's not like there isn't a history that the data provided by Amarex was inadequate, hence the RTF CytoDyn received. Is it so unreasonable to verify that the same thing didn't occur with CD12?
It's not like there isn't a history that the data provided by Amarex was inadequate, hence the RTF CytoDyn received. Is it so unreasonable to verify that the same thing didn't occur with CD12?
(2)
(3)Scroll down for more posts ▼
